The FDA approved the drug after the manufacturer submitted 19 clinical studies involving nearly 2,600 patients. The tests showed the drug worked to eliminate moderate to severe chin fat. Currently, the only other way to delete your double chin is to have surgery
, having the fat removed with traditional liposuction. In the past, a drug called Lipodissolve, also known on the streets of Beverly Hills as "lunchtime lipo," prompted an FDA warning letter
in 2010 that suggested that treatment could cause permanent scarring and skin deformities.
Side effects for a small number of patients in the Kybella drug trials included nerve injury in the jaw that lead to a lopsided smile or facial weakness. It also may cause bruising, swelling, redness and some pain in some patients. Insurance does not cover this treatment.
While this drug may be a success for your neck, don't expect to see it dissolving fat in other problem places, the FDA warns.
"It is important to remember that Kybella is only approved for the treatment of fat occurring below the chin, and it is not known if Kybella is safe or effective for treatment outside of this area," Dr. Amy G. Egan, deputy director of the Office of Drug Evaluation III in the FDA's Center for Drug Evaluation and Research, said in a news release.
The drug should be commercially available in June, the company said. Just in time for summer vacation selfie season.